PLLAX | VSMAX | PLLAX / VSMAX | |
Total Expense Ratio | 1.12 | 0.05 | 2,240% |
Annual Report Gross Expense Ratio | 1.12 | 0.05 | 2,240% |
Fund Existence | 20 years | 25 years | - |
Gain YTD | 6.753 | 2.517 | 268% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.13B | 154B | 1% |
Annual Yield % from dividends | 0.06 | 1.37 | 4% |
Returns for 1 year | 7.49 | 9.17 | 82% |
Returns for 3 years | 11.56 | 20.48 | 56% |
Returns for 5 years | 34.17 | 57.73 | 59% |
Returns for 10 years | 25.88 | 113.12 | 23% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
REPIX | 40.98 | 0.40 | +0.99% |
ProFunds Real Estate UltraSector Inv | |||
FBTAX | 30.03 | 0.26 | +0.87% |
Fidelity Advisor Biotechnology A | |||
FIJZX | 54.15 | -0.13 | -0.24% |
Fidelity Advisor Consumer Discret Z | |||
PWCIX | 88.75 | -0.23 | -0.26% |
Principal Capital Appreciation Inst | |||
TMITX | 11.34 | -0.06 | -0.53% |
Transamerica Mid Cap Growth I3 |